Infectious Diseases – News and Features

News
Sequenta Secures $13 Million in Series B Financing
Molecular Diagnostics platform will enable better monitoring of immune system in human disease.

News
Scientists Trace Origin of Recent Cholera Epidemic in Haiti
The finding supports the notion that the cholera bacteria fueling the outbreak arrived on the island via recent visitors.

News
Genome of Barley Disease Reveals Surprises
Scientists have sequenced the genome of a major fungal disease that affects barley and other cereal crops, a breakthrough that could lead to significant advances in our understanding of how plant diseases evolve. The research, published today in the journal Science, suggests that parasites within the genome of the fungus help the disease to adapt and overcome the plant's defences.

News
Scientists Use Fluorescent Genes to Trace Honey Fungus
Scientists develop new DNA technique to aid crops and trees at risk from deadly 'honey fungus'

News
Agilent Technologies Collaborates with UC Davis on Breakthrough Food-Safety Research
Technology aims to revolutionize food safety by reducing identification time of food-borne bacteria.

News
AiCuris Completes Phase II Genital Herpes Trial with AIC316 Ahead of Time
Trial aimed to investigate different doses of a new antiviral drug in subjects with genital HSV Type 2 infection.

News
Lab21 Secures new Patents in Hepatitis C Drug Resistance and Fluorescent Carbon-Based Nanoparticle Technology
New patent refers to technology allowing the genotypic identification of drug resistant mutations in the 4 major global genotypes of HCV.

News
Genome of Barley Disease Reveals Surprises
New research suggests that parasites within the genome of the fungus help the disease to adapt and overcome the plant's defences.

News
CLSI Publishes Quality Practices in Noninstrumented Point-of-Care Testing
New instructional guideline delivers laboratory science concepts and activities for increasing knowledge and quality of laboratory testing.

News
Cytheris Announces Interim Results of Phase I Study of Recombinant Human Interleukin-7
CYT107 has shown to promote T-cell recovery following T-cell depleted allogeneic hematopoietic stem cell transplantation.
Advertisement